Ledger.Open graph →
SEC Form D · filed August 23, 2019

Landos Biopharma, Inc

Offering
$60.3M
Sold
$60.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BLACKSBURG, VA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Christopher Garabedian · Philadelphia, PADirectorJosep Bassaganya-Riera · Blacksburg, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗